Walleye Capital LLC Has $8.96 Million Holdings in Teleflex Incorporated $TFX

Key Points

• Walleye Capital LLC significantly increased its holdings in Teleflex by 868.6% during the first quarter, owning 64,850 shares valued at approximately $8.96 million.
• Multiple large investors, including Dimensional Fund Advisors and Public Sector Pension Investment Board, also boosted their positions in Teleflex, reflecting strong institutional interest in the company.
• Teleflex announced a $0.34 quarterly dividend to be paid on September 15, and reported better-than-expected earnings of $3.73 EPS, exceeding analyst estimates.

Walleye Capital LLC boosted its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 868.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 64,850 shares of the medical technology company's stock after buying an additional 58,155 shares during the period. Walleye Capital LLC owned 0.15% of Teleflex worth $8,962,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in TFX. MassMutual Private Wealth & Trust FSB increased its position in Teleflex by 103.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock worth $27,000 after buying an additional 100 shares during the period. Banque Cantonale Vaudoise acquired a new stake in Teleflex in the first quarter worth $27,000. Costello Asset Management INC acquired a new stake in Teleflex in the first quarter worth $28,000. Brooklyn Investment Group increased its position in Teleflex by 258.6% in the first quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company's stock worth $29,000 after buying an additional 150 shares during the period. Finally, Whipplewood Advisors LLC increased its position in Teleflex by 7,700.0% in the first quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company's stock worth $32,000 after buying an additional 231 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Price Performance

TFX stock traded down $3.22 during trading hours on Thursday, hitting $126.28. 436,361 shares of the stock traded hands, compared to its average volume of 586,802. The stock has a 50-day simple moving average of $118.88 and a 200 day simple moving average of $129.69. Teleflex Incorporated has a one year low of $108.90 and a one year high of $249.90. The company has a market cap of $5.58 billion, a P/E ratio of 29.71, a P/E/G ratio of 1.81 and a beta of 1.08. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, beating the consensus estimate of $3.36 by $0.37. The business had revenue of $780.90 million during the quarter, compared to analysts' expectations of $771.53 million. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The company's quarterly revenue was up 4.2% on a year-over-year basis. During the same quarter last year, the business posted $3.42 earnings per share. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. Equities analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Friday, August 15th will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.1%. The ex-dividend date is Friday, August 15th. Teleflex's payout ratio is presently 32.00%.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Mizuho increased their target price on Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a research report on Friday, August 1st. Wall Street Zen raised Teleflex from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 2nd. Truist Financial lowered their price target on Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a report on Monday, May 5th. Wells Fargo & Company lowered their price target on Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a report on Friday, August 1st. Finally, Morgan Stanley lowered their price target on Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a report on Monday, May 5th. One analyst has rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $141.57.

Insider Activity

In related news, Director Andrew A. Krakauer acquired 1,000 shares of the business's stock in a transaction on Tuesday, August 5th. The shares were purchased at an average price of $115.25 per share, for a total transaction of $115,250.00. Following the acquisition, the director owned 7,192 shares in the company, valued at approximately $828,878. This represents a 16.15% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Liam Kelly acquired 1,500 shares of the business's stock in a transaction on Tuesday, August 5th. The shares were bought at an average price of $115.07 per share, for a total transaction of $172,605.00. Following the acquisition, the chief executive officer owned 45,267 shares in the company, valued at approximately $5,208,873.69. This trade represents a 3.43% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have acquired 5,500 shares of company stock worth $633,590. 1.40% of the stock is owned by company insiders.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.